24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Giant Axonal Neuropathy (GAN) is a rare, inherited neurological disorder affecting nerve cells. Learn about its symptoms, causes, diagnosis, and the promising research in gene therapy.

Giant Axonal Neuropathy (GAN) is a rare, inherited disorder that affects the nervous system. It is a progressive neurodegenerative disease, meaning it worsens over time. GAN is caused by a genetic mutation that disrupts the normal functioning of nerve cells, particularly the axons, which are responsible for transmitting signals between the brain, spinal cord, and the rest of the body. This disruption leads to a buildup of protein filaments within the axons, causing them to enlarge and eventually malfunction or die. Consequently, the communication between nerve cells is impaired, leading to a range of neurological symptoms.
GAN is characterized by the enlarged size of the nerve axons, hence the name "giant axonal neuropathy." It is an autosomal recessive disorder, meaning an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. Parents who carry only one copy of the mutated gene typically do not show any symptoms themselves.
The symptoms of GAN usually begin to appear in early childhood, often before the age of 5. However, some individuals with milder forms may experience symptom onset at a later age. The progression and severity of symptoms can vary significantly among affected individuals.
As the disease progresses, more severe symptoms can develop, impacting various bodily functions:
Most children diagnosed with GAN will require a wheelchair between the ages of 10 and 20 years old. The life expectancy for individuals with GAN can vary, with many living into their 20s, especially with supportive care.
GAN is caused by a mutation in the GAN1 gene. This gene provides instructions for making a protein that plays a crucial role in breaking down and recycling protein filaments within the axons. In individuals with GAN, this process is impaired. The protein filaments, instead of being broken down, accumulate and enlarge the axons, disrupting nerve signal transmission.
Diagnosing GAN typically involves a combination of clinical evaluation, neurological examination, and genetic testing.
Currently, there is no cure for Giant Axonal Neuropathy. Treatment focuses on managing symptoms, improving quality of life, and slowing disease progression. This often involves a multidisciplinary approach:
Significant progress is being made in the field of gene therapy for GAN. Researchers have been conducting clinical trials, including gene replacement therapy, for individuals aged 3 and older. These trials aim to introduce a functional copy of the GAN1 gene to potentially correct the underlying cause of the disorder. While still in the research phase, gene therapy offers hope for future treatments.
As GAN is a genetic disorder, it cannot be prevented in the traditional sense. However, for families with a known history of GAN, genetic counseling can be beneficial. Genetic counseling can help individuals understand their risk of passing on the condition and discuss options for family planning, including prenatal testing.
If you notice any of the early symptoms of GAN in a child, such as difficulty walking, unusual numbness, or distinctively kinky and pale hair, it is crucial to consult a pediatrician or a neurologist promptly. Early diagnosis and intervention can help in managing the condition and providing the best possible care and support for the child and family.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026